Keynotes

Frits Rosendaal is professor of Clinical Epidemiology at the LUMC in Leiden. His research is in the field of cardiovascular disease, with a focus on blood coagulation.

Besides that, he is active in the field of research integrity, as chair of the Committee on Scientific Integrity (CWI) of LUMC and Leiden University, member of the national committee on scientific integrity in Austria (OeAWI), chair of the policy group Scientific Integrity of the League of European Research Universities (LERU), Council member of the Committee on Publication Ethics (COPE) and Editor-in-Chief of Research Integrity and Peer Review. From his experience in the field he will discuss theory and practice of scientific integrity, and how research into this subject is performed.

Jelle Goeman is professor of biostatistics at Leiden University Medical Center, where he is the head of the medical statistics group. His research focuses on high-dimensional data analysis, with applications to omics and neuroimaging, and in multiple testing problems.

He develops novel statistical theory and methods, but is also involved in many clinical and biomedical studies as a statistical advisor.

Suzanne Cannegieter is a professor of Clinical Epidemiology with a focus on Thrombosis and Haemostasis at the Leiden University Medical Center in the Netherlands. She is involved in several (inter)national multicenter studies as PI, WP leader or methodological advisor.

For her studies she combines the latest epidemiological and statistical techniques with pathophysiological and clinical knowledge. Topics include epidemiology (e.g., risks of venous thromboembolism (VTE) in (specific) populations), pathophysiology (e.g., role of hormones, obesity in the development of VTE), prediction (risk assessment models for situations at high risk for VTE) and optimal prevention (RCTs on individualized anticoagulant dosing). She is also co-Editor in Chief of the Journal of Thrombosis and Haemostasis.

Prof. Dr. Agnes Kant is an epidemiologist and has been the director of the Lareb Adverse Drug Reactions Centre since 2013. Lareb is the reporting and knowledge centre for adverse drug reactions and vaccines and their use during pregnancy and breastfeeding in the Netherlands. Since May 2024, she has been a special professor of pharmacovigilance innovation at the LUMC/Leiden University.

She studied Health Sciences at Radboud University in Nijmegen. She graduated as an epidemiologist in 1989. She worked as a scientific researcher at Radboud University for 5 years.

In 1997, she obtained her PhD with a thesis on the organisation of cervical cancer screening. From 1998 to 2010, she was a member of the House of Representatives for the Socialist Party. In the period 1998-2008, she mainly served as a spokesperson in the field of healthcare. From 2008 to 2010, she was the leader of the Socialist Party.

Helga Gardarsdottir is professor in use of Real world data for decision making on medicines at the Division of Pharmacoepidemiology & Clinical Pharmacology (Utrecht University, NL). Additionally, she holds the position of adjunct professor of Pharmacoepidemiology at the University of Iceland.

Her research focuses on the application and development of innovative approaches to generate and analyze real-world data on the safety and effectiveness of medicines for regulatory and clinical decision-making.

She has led and participated in several international research projects, as well as multiple EMA-tendered studies through the EU Pharmacoepidemiology and Pharmacovigilance Research Network. She is currently the co-chair of the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP) steering group and an associate editor of the journal ‘Pharmacoepidemiology & Drug Safety’.

Marieke Adriaanse is Professor ‘Behavioral Interventions in Population Health’ within Leiden University’s and the Leiden University Medical Center’s interdisciplinary program Population Health at the Health Campus The Hague.

Marieke is trained as a health and social psychologist. She studies human behavior and behavior change in the health domain, combining fundamental and applied research. Her current work at the Health Campus is mainly interdisciplinary. She collaborates with disciplines such as medicine, epidemiology, governance, and data science to study how behavioral insights can be applied effectively and sustainably to promote healthy lifestyle and reduce health inequalities.